Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 16Neoplasm Metastasis 3Urologic Diseases 1Salivary Gland Neoplasms 1Recurrence 1Radiation Injuries 1Prostate Cancer Metastatic 1Oligorecurrent and Oligoprogressive Prostate Cancer Patients 1Neoplasms 1Neoplasm Recurrence, Local 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Intraprostatic Prostate Cancer 1Gastrointestinal Diseases 1

Interventions

apalutamide 1Radiotherapy 1Glutamyl Aminopeptidase 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) × Androgen Antagonists × Clear all
NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting
566 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡